Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial [NA]

View source ↗

Summary

This entry notes that the PROACT trial, a multilevel intervention to increase colorectal cancer screening after abnormal fecal immunochemical test results, is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Colorectal Carcinoma | NA | Status: ENROLLING_BY_INVITATION